These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9122687)

  • 1. New tumor suppressor found--twice.
    Pennisi E
    Science; 1997 Mar; 275(5308):1876-8. PubMed ID: 9122687
    [No Abstract]   [Full Text] [Related]  

  • 2. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
    Li J; Yen C; Liaw D; Podsypanina K; Bose S; Wang SI; Puc J; Miliaresis C; Rodgers L; McCombie R; Bigner SH; Giovanella BC; Ittmann M; Tycko B; Hibshoosh H; Wigler MH; Parsons R
    Science; 1997 Mar; 275(5308):1943-7. PubMed ID: 9072974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
    Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
    Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.
    Li DM; Sun H
    Cancer Res; 1997 Jun; 57(11):2124-9. PubMed ID: 9187108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.
    Tashiro H; Blazes MS; Wu R; Cho KR; Bose S; Wang SI; Li J; Parsons R; Ellenson LH
    Cancer Res; 1997 Sep; 57(18):3935-40. PubMed ID: 9307275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a pseudogene that can masquerade as a mutant allele of the PTEN/MMAC1 tumor suppressor gene.
    Whang YE; Wu X; Sawyers CL
    J Natl Cancer Inst; 1998 Jun; 90(11):859-61. PubMed ID: 9625175
    [No Abstract]   [Full Text] [Related]  

  • 7. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.
    Wang SI; Parsons R; Ittmann M
    Clin Cancer Res; 1998 Mar; 4(3):811-5. PubMed ID: 9533551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
    Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
    Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN gene and integrin signaling in cancer.
    Tamura M; Gu J; Tran H; Yamada KM
    J Natl Cancer Inst; 1999 Nov; 91(21):1820-8. PubMed ID: 10547389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic structure of a copy of the human TPTE gene which encompasses 87 kb on the short arm of chromosome 21.
    Guipponi M; Yaspo ML; Riesselman L; Chen H; De Sario A; Roizès G; Antonarakis SE
    Hum Genet; 2000 Aug; 107(2):127-31. PubMed ID: 11030409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain.
    Furnari FB; Lin H; Huang HS; Cavenee WK
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12479-84. PubMed ID: 9356475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
    Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of brain tumors.
    Boudreau CR; Liau LM
    Clin Neurosurg; 2004; 51():81-90. PubMed ID: 15571131
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
    Steck PA; Pershouse MA; Jasser SA; Yung WK; Lin H; Ligon AH; Langford LA; Baumgard ML; Hattier T; Davis T; Frye C; Hu R; Swedlund B; Teng DH; Tavtigian SV
    Nat Genet; 1997 Apr; 15(4):356-62. PubMed ID: 9090379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.
    Vlietstra RJ; van Alewijk DC; Hermans KG; van Steenbrugge GJ; Trapman J
    Cancer Res; 1998 Jul; 58(13):2720-3. PubMed ID: 9661880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
    Herman JG; Jen J; Merlo A; Baylin SB
    Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
    Guldberg P; thor Straten P; Birck A; Ahrenkiel V; Kirkin AF; Zeuthen J
    Cancer Res; 1997 Sep; 57(17):3660-3. PubMed ID: 9288767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations of PTEN in glioblastoma multiforme.
    Wang SI; Puc J; Li J; Bruce JN; Cairns P; Sidransky D; Parsons R
    Cancer Res; 1997 Oct; 57(19):4183-6. PubMed ID: 9331071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine mapping of a region of common deletion on chromosome arm 10p in human glioma.
    Voesten AM; Bijleveld EH; Westerveld A; Hulsebos TJ
    Genes Chromosomes Cancer; 1997 Oct; 20(2):167-72. PubMed ID: 9331567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.